End of the Bottom Formation? Schrödinger Presents Initial Positive Results for SGR-1505, a Drug Developed Using an AI-Powered Platform.

Schrödinger (SDGR) is a software and biotechnology company that has specialized in the development of computer-assisted tools for drug and material research for nearly 35 years. The company offers a unique platform that combines physics-based methods with machine learning to accelerate the discovery and development of new drugs and materials. In the first quarter, Schrödinger continued its growth trajectory. The software division grew by 46% to $48.8 million, driven by larger customer contracts and the increasing adoption of cloud-based solutions....